Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1919 E Thomas Rd
Phoenix, AZ 85016Phone+1 602-933-0920
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 2011 - 2014
Baylor College of Medicine (Houston)Residency, Pediatrics, 2008 - 2011
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2008
Certifications & Licensure
AZ State License 2019 - 2026
CO State License 2010 - 2021
OH State License 2014 - 2016
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
- Tocilizumab in Children With ACP Start of enrollment: 2019 Sep 16
- Pediatric Long-Term Follow-up and Rollover Study Start of enrollment: 2019 Nov 04
- Join now to see all
Publications & Presentations
PubMed
- Pediatric Central Nervous System Embryonal Tumors: Presentation, Diagnosis, Therapeutic Strategies, and Survivorship-A Review.Rebecca Ronsley, Bonnie Cole, Tyler Ketterl, Jason Wright, Ralph Ermoian
Pediatric Neurology. 2024-12-01 - 3 citationsTowards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation.Ariana M Familiar, Anahita Fathi Kazerooni, Arastoo Vossough, Jeffrey B Ware, Sina Bagheri
Neuro-Oncology. 2024-09-05 - 2 citationsOutcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries.Alexander T Nelson, Anne K Harris, Dave Watson, Junne Kamihara, Kenneth S Chen
Gynecologic Oncology. 2024-07-01
Journal Articles
- Correction to: A Suggestion to Introduce the Diagnosis of “Diffuse Midline Glioma of the Pons, H3 K27 Wildtype (WHO Grade IV)”Lindsey M Hoffman, Maryam Fouladi, Acta Neuropathologica
Press Mentions
- SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain CancerSeptember 13th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
